Autopilot 2.0 Chain AI agents into full outbound flows Read more →
Product
AI Sales Agents Prospector Intent & Signals Visitor Tracking Reply Handler Email Automation LinkedIn Automation Autopilot
Solutions
TAM sourcing Automated outbound Sales RevOps Enterprise Startups
Resources
The Report Blog Salestools University Guides GPT Prompts ROI Calculator Help Center
Company
Our Team Careers Customers Partner Program Pricing Changelog
Language
Get a demo Start free trial Log in

Het rapport

Diepgaande analyses van bedrijfsfinanciering, groeistrategieën en marktinzichten van 's werelds meest innovatieve bedrijven

53 rapporten en meer

Dagelijks bijgewerkt met de nieuwste marktinformatie
Synthetic Biology
Ginkgo Bioworks

Ginkgo Bioworks transforms synthetic biology industry with $350M IPO at $15B valuation

Ginkgo Bioworks achieves $15B valuation through $350M IPO funding, establishing dominance in the synthetic biology market with innovative synthetic biology platform for organism design and manufacturing.

Michael Chang
Sep 3, 2025
0 min read•$350M
Synthetic Biology
BioSynthetic Materials

BioSynthetic Materials Raises $720M Series D for Revolutionary Synthetic Biology Technology

BioSynthetic Materials secures $720M in Series D funding at $10.8B valuation to pioneer breakthrough synthetic biology technology.

Editorial Team
Sep 10, 2025
0 min read•$720M
Synthetic Biology
Zymergen

Zymergen transforms synthetic biology industry with $300M Series C at $3.2B valuation

Zymergen achieves $3.2B valuation through $300M Series C funding, establishing dominance in the synthetic biology market with innovative biomanufacturing platform for materials and chemicals.

Michael Chang
Aug 6, 2025
0 min read•$300M
Biotech
Twist Bioscience

Twist Bioscience secures $120M Series D for biotech innovation

Twist Bioscience raises $120M in Series D funding to advance its synthetic biology company manufacturing dna sequences and accelerate market growth.

Anna Rodriguez
Aug 22, 2025
0 min read•$120M
Biotech
BioSynth Labs

BioSynth Labs raises $380M Series B in September 2025 funding round

BioSynth Labs secures $380M in Series B funding in September 2025, reaching $3.2B valuation to advance its synthetic biology platform for sustainable chemical manufacturing.

Morgan Foster
Sep 12, 2025
0 min read•$380M
Biotechnology
CanSino Biologics

CanSino Biologics Headquarters - Office Location & Address

Discover CanSino Biologics's headquarters at West Area of TEDA, Tianjin, 300457. Vaccine research and development. Learn about the office facilities and work environment.

Editorial Team
Oct 5, 2025
0 min read
Biotechnology
China Biologic Products

China Biologic Products Headquarters - Office Location & Address

Discover China Biologic Products's headquarters at 17 Science Park Rd, Beijing, 100176. Plasma-based biopharmaceutical products. Learn about the office facilities and work environment.

Editorial Team
Oct 5, 2025
0 min read
Biotech
Absci

Absci Raises $125M Series D

AI-powered drug discovery platform using deep learning and synthetic biology to design novel antibodies and biologics

David Chen
Oct 23, 2025
0 min read•$125M Series D
Biotech
Forge Biologics

Forge Biologics Raises $120M Series C

Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines

Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Pagina 1

Tonen van 9 rapporten • Pagina 1 • Categorie: all

Loop voor op de markt

Ontvang wekelijkse inzichten in uw inbox. Geen spam, alleen intelligentie.